IVVD FY 2023 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena

IVVDInvivyd, Inc.

$257M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$213M

Net Income

-$199M

EPS (Diluted)

$-1.81

Cash Flow

Operating Cash Flow

-$173M

Free Cash Flow

-$174M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$229M

Total Liabilities

$52M

Stockholders' Equity

$177M

Cash & Equivalents

$201M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$213M	-$248M	+14.2%
Net Income	-$199M	-$241M	+17.7%